All Vaccinology articles – Page 22
-
NewsBiovac signs deal with IVI to deliver oral cholera vaccine for African and global markets
South African based Bio-pharmaceutical company Biovac has concluded a ground-breaking licensing and technology transfer agreement with the International Vaccine Institute (IVI), a non-profit international organisation headquartered in South Korea, for the manufacture of an oral cholera vaccine (OCV).
-
NewsHidden Nsp1 cavity means Covid’s Spike protein is no longer the only target
Researchers have revealed the existence of a hidden ’’pocket’ on the surface of the non-structural protein Nsp1 on the surface of the Covid-19 virus which could offer a potential drug target and alternative to the Spike protein targeted by vaccines.
-
NewsIntranasal COVID vaccine works against variants in animals
Researchers have developed an intranasal vaccine against Covid-19 that can fight off the original virus and two variants in hamsters.
-
NewsNew immersive nanovaccine tackles Flavobacterium diseases in fish without injection
Researchers from the Faculty of Veterinary Science at Chulalongkorn University in Thailand have developed a nanovaccine to prevent bacterial gill diseases in freshwater fish species such as Tilapia and freshwater Asian sea bass.
-
NewsmRNA vaccines significantly reduce severity of Delta, Omicron COVID-19 infections
People who have received several doses of an mRNA COVID-19 vaccine are more likely to have milder illnesses if infected with Delta or Omicron variants than those who are unvaccinated.
-
FeaturesBlue plaque microbiology
Marking sites associated with notable people or events is an estimable and widespread practice.
-
FeaturesParental decisions about vaccination: a paediatrician’s perspective
Vaccine hesitancy is a relatively new term for a phenomenon that is as old as vaccination itself
-
FeaturesMitigate or suppress—coming to grips with the COVID-19 pandemic
In the absence of an efficient vaccine, the control of the COVID-19 pandemic currently relies on non-pharmaceutical interventions.
-
FeaturesAssuring the safety of vaccines
A vaccine undergoes a comprehensive regime of testing, and its use is subject to continuous vigilance throughout its lifecycle to ensure safety, efficacy and quality.